Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cyclerion Therapeutics (CYCN) Current Leases (2019 - 2021)

Cyclerion Therapeutics (CYCN) has disclosed Current Leases for 3 consecutive years, with $1.4 million as the latest value for Q1 2021.

  • For Q1 2021, Current Leases fell 47.53% year-over-year to $1.4 million; the TTM value through Mar 2021 reached $1.4 million, down 47.53%, while the annual FY2020 figure was $3.3 million, 3.71% down from the prior year.
  • Current Leases hit $1.4 million in Q1 2021 for Cyclerion Therapeutics, down from $3.3 million in the prior quarter.
  • Across five years, Current Leases topped out at $3.4 million in Q4 2019 and bottomed at $866000.0 in Q2 2019.
  • Average Current Leases over 3 years is $2.6 million, with a median of $3.0 million recorded in 2020.
  • Year-over-year, Current Leases surged 221.82% in 2020 and then crashed 47.53% in 2021.
  • Cyclerion Therapeutics' Current Leases stood at $3.4 million in 2019, then fell by 3.71% to $3.3 million in 2020, then crashed by 57.49% to $1.4 million in 2021.
  • According to Business Quant data, Current Leases over the past three periods came in at $1.4 million, $3.3 million, and $3.1 million for Q1 2021, Q4 2020, and Q3 2020 respectively.